500 Fifth St, NW
Washington, DC 20001
The latest news from HMD, including information about new reports, activities, meetings, and other noteworthy events.
Displaying: 1 to 2 of 2 News and Announcements
The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies, a new report from the Institute of Medicine, examines evidence about the schedule's safety and recommends the best way to conduct any needed investigations. Members of the committee that wrote the report will discuss their conclusions and recommendations during a one-hour telephone briefing starting at 11 a.m. EST Wednesday, Jan. 16.
Researching the safety and effectiveness of new drugs is more challenging in children than adults. Congress sought to boost studies involving pediatric patients by creating legislation that provides economic incentives and adds requirements for such research. Safe and Effective Medicines for Children: Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act, a new report from the Institute of Medicine, provides an independent assessment of several aspects of the studies carried out under this legislation, including the ethical challenges and the timeliness and usefulness of the clinical data that has been generated.